Panion & BF Biotech Inc Working Capital to Net Assets Ratio
Panion & BF Biotech Inc working capital to net assets ratio. Panion & BF Biotech Inc (1760) has a Working Capital to Net Assets ratio of 21.1% as of September 2025. Working capital of NT$401.09 Million (current assets of NT$1.38 Billion minus current liabilities of NT$982.84 Million) is measured against net assets of NT$1.90 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Panion & BF Biotech Inc (2009–2024)
Working capital to net assets ratio of Panion & BF Biotech Inc from 2009 to 2024. This chart shows how Panion & BF Biotech Inc's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 21.1%, reflecting working capital of NT$401.09 Million against net assets of NT$1.90 Billion TWD. See Panion & BF Biotech Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Panion & BF Biotech Inc Working Capital to Net Assets Ratio by Year (2009–2024)
Panion & BF Biotech Inc working capital to net assets ratio by year from 2009 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Panion & BF Biotech Inc from 2009 to 2024, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Panion & BF Biotech Inc assets under control.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 25.1% | NT$482.99 Million | NT$1.92 Billion | NT$1.51 Billion | NT$1.03 Billion | ▲ +2.8 pp |
| 2023 | 22.3% | NT$425.79 Million | NT$1.91 Billion | NT$1.48 Billion | NT$1.05 Billion | ▼ -1.5 pp |
| 2022 | 23.8% | NT$477.71 Million | NT$2.01 Billion | NT$1.40 Billion | NT$921.58 Million | ▼ -3.8 pp |
| 2021 | 27.6% | NT$534.04 Million | NT$1.93 Billion | NT$1.27 Billion | NT$740.49 Million | ▼ -13.4 pp |
| 2020 | 41.0% | NT$508.36 Million | NT$1.24 Billion | NT$1.45 Billion | NT$946.01 Million | ▼ -20.7 pp |
| 2019 | 61.6% | NT$838.17 Million | NT$1.36 Billion | NT$1.23 Billion | NT$392.17 Million | ▼ -7.0 pp |
| 2018 | 68.7% | NT$927.22 Million | NT$1.35 Billion | NT$1.35 Billion | NT$422.23 Million | ▲ +17.3 pp |
| 2017 | 51.3% | NT$428.80 Million | NT$835.25 Million | NT$762.74 Million | NT$333.94 Million | ▲ +4.8 pp |
| 2016 | 46.5% | NT$374.91 Million | NT$806.41 Million | NT$685.93 Million | NT$311.02 Million | ▼ -1.2 pp |
| 2015 | 47.7% | NT$369.35 Million | NT$775.03 Million | NT$684.91 Million | NT$315.56 Million | ▼ -0.6 pp |
| 2014 | 48.3% | NT$343.27 Million | NT$710.84 Million | NT$649.35 Million | NT$306.08 Million | ▼ -5.0 pp |
| 2013 | 53.3% | NT$349.75 Million | NT$656.55 Million | NT$607.50 Million | NT$257.74 Million | ▲ +19.6 pp |
| 2012 | 33.7% | NT$93.94 Million | NT$278.86 Million | NT$537.85 Million | NT$443.90 Million | ▼ -9.5 pp |
| 2011 | 43.1% | NT$128.12 Million | NT$296.98 Million | NT$546.83 Million | NT$418.71 Million | ▼ -21.2 pp |
| 2010 | 64.3% | NT$194.06 Million | NT$301.62 Million | NT$537.10 Million | NT$343.04 Million | ▲ +36.2 pp |
| 2009 | 28.2% | NT$91.47 Million | NT$324.61 Million | NT$568.66 Million | NT$477.19 Million | — |